A press release from Bharat biotech said the vaccine maker said the study has been accepted and published in Lancet Infectious diseases, peer-reviewed high impact factor journal.
"For the coming period, the company will focus on pending facility maintenance, process and facility optimization activities," Bharat Biotech said in a statement.
DUBLIN (BUSINESS WIRE) The "Assessment of India's Pharmaceutical Market 2021" report has been added to ResearchAndMarkets.com's offering.The report highlights key dynamics of the global and India's pharmaceutical market. The current market scenario, growing opportunity in the sector and the impact of the Covid-19.
Regular Market Approval Granted For Covishield, Covaxin For Use In Adult Population swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.
India s drug regulator on Thursday granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, official sources said. The approval was granted under the New Drugs and Clinical Trials Rules, 2019. Under the conditions, the firms shall submit data of ongoing clinical trials and the vaccines to be supplied for programmatic setting. Adverse event following immunisation will continue to be monitored. The Drugs Controller